Jump Financial LLC Grows Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Jump Financial LLC increased its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 61.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 55,573 shares of the medical instruments supplier's stock after purchasing an additional 21,244 shares during the period. Jump Financial LLC's holdings in DENTSPLY SIRONA were worth $1,055,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Riverview Trust Co purchased a new stake in DENTSPLY SIRONA during the fourth quarter worth approximately $26,000. MassMutual Private Wealth & Trust FSB lifted its holdings in shares of DENTSPLY SIRONA by 648.4% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock valued at $27,000 after buying an additional 1,232 shares during the period. UMB Bank n.a. increased its holdings in shares of DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after purchasing an additional 564 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in DENTSPLY SIRONA by 700.0% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock worth $33,000 after purchasing an additional 1,568 shares during the last quarter. Finally, Signaturefd LLC increased its stake in shares of DENTSPLY SIRONA by 513.3% during the 4th quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier's stock worth $84,000 after purchasing an additional 3,706 shares in the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Price Performance

DENTSPLY SIRONA stock traded up $0.06 during trading hours on Friday, reaching $13.77. 1,318,942 shares of the stock were exchanged, compared to its average volume of 2,958,349. The stock has a 50 day moving average of $15.19 and a two-hundred day moving average of $18.41. The company has a market cap of $2.74 billion, a P/E ratio of -6.63, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a twelve month low of $12.16 and a twelve month high of $31.00.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were issued a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.65%. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -14.07%.

Insider Buying and Selling

In other news, Director Gregory T. Lucier bought 15,142 shares of the firm's stock in a transaction on Monday, March 3rd. The stock was acquired at an average price of $16.51 per share, with a total value of $249,994.42. Following the transaction, the director now owns 81,971 shares of the company's stock, valued at $1,353,341.21. This trade represents a 22.66 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.52% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of brokerages have weighed in on XRAY. StockNews.com lowered DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Wells Fargo & Company cut their price objective on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a report on Friday, February 28th. Robert W. Baird cut their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research note on Friday, February 28th. Barrington Research decreased their price objective on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating for the company in a report on Friday, February 28th. Finally, Mizuho cut their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a research report on Thursday, March 13th. Thirteen equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $22.58.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.